Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cirius Therapeutics
Cirius Therapeutics
Cirius withdraws $86M IPO as vaunted 'Year of NASH' draws to brutal close
Endpoints
Mon, 12/23/19 - 11:50 pm
Cirius Therapeutics
NASH
Company with NASH Candidate in Ph IIb Trials Updates $86 Million IPO filing
CP Wire
Thu, 02/14/19 - 09:40 am
Cirius Therapeutics
NASH
MSDC-0602K
IPOs
Company with NASH Candidate in Ph IIb Trials Updates $86 Million IPO filing
Thu, 02/14/19 - 09:38 am
Cirius Therapeutics
NASH
MSDC-0602K
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
Fierce Biotech
Mon, 01/14/19 - 11:35 am
IPOs
Kaleido Biosciences
Cirius Therapeutics
NASDAQ
JPMHC 2019
government shutdown
Kaleido Bio and Cirius Join an IPO Queue Stalled by Federal Shutdown
Xconomy
Fri, 01/11/19 - 08:14 pm
IPOs
government shutdown
Kaleido Biosciences
Cirius Therapeutics
Cirius Therapeutics Completes Enrollment in Phase 2b EMMINENCE Trial in NASH
CP Wire
Wed, 05/2/18 - 07:12 pm
Cirius Therapeutics
NASH
MSDC-0602K
Cirius Therapeutics Completes Enrollment in Phase 2b EMMINENCE Trial in NASH
Wed, 05/2/18 - 09:22 am
Cirius Therapeutics
NASH
MSDC-0602K